RHESONATIV 750UI / ml solution for injection medication leaflet

J06BB01 anti-D immunoglobulin • Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins

Anti-D immunoglobulin is a medication used to prevent Rh isoimmunization in Rh-negative women who have been exposed to Rh-positive blood, such as during pregnancy or childbirth. It contains antibodies that neutralize Rh-positive cells, thereby preventing the formation of antibodies against them.

The medication is administered via intramuscular or intravenous injection, according to the doctor's instructions. It is effective in preventing hemolytic complications in subsequent pregnancies.

Side effects may include pain at the injection site, fever, headache, and, in rare cases, severe allergic reactions. Close monitoring is essential during treatment.

Consult your doctor to discuss the benefits and risks of treatment with anti-D immunoglobulin. Follow the administration instructions to ensure therapy effectiveness.

General data about RHESONATIV 750UI / ml

Substance: anti-D immunoglobulin

Date of last drug list: 01-08-2019

Commercial code: W65902001

Concentration: 750UI / ml

Pharmaceutical form: solution for injection

Packing volume: 1ml

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: OCTAPHARMA AB - SUEDIA

Holder: OCTAPHARMA (IP) SPRL - BELGIA

Number: 14524/2022/01

Shelf life: 30 months-after packing for marketing; after the first opening a fiolei-it is used immediately

Concentrations available for anti-D immunoglobulin

300mcg, 300mcg/2ml, 625UI/ml, 750UI/ml